SCHEMBL5252916

SCHEMBL5252916

COC(=O)Oc1c(N)sc2c1CCCC2

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 13/20 0.57
▸ MAPT P10636 10/20 0.57
▸ HPGD P15428 9/20 0.57
▸ HSD17B10 Q99714 8/20 0.57
▸ KDM4E B2RXH2 8/20 0.57
▸ ALOX15 P16050 7/20 0.57
▸ MEN1 O00255 7/20 0.57
▸ KMT2A Q03164 7/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ THRB P10828 1/20 0.57
▸ TSHR P16473 3/20 0.50
▸ CASP1 P29466 1/20 0.50
▸ CASP7 P55210 1/20 0.50
▸ USP2 O75604 1/20 0.49
▸ MAPK1 P28482 2/20 0.48
▸ GAA P10253 2/20 0.48
▸ RECQL P46063 1/20 0.45
▸ LMNA P02545 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10879529 0.82 ADORA1 (0.42) ALDH1A1MAPTHPGDHSD17B10KDM4E
SCHEMBL2179728 0.74 ALDH1A1 (0.70) ALDH1A1MAPTHPGDHSD17B10KDM4E
SCHEMBL10714412 0.73 ALDH1A1 (0.68) ALDH1A1MAPTHPGDHSD17B10KDM4E
SCHEMBL7421874 0.71 ALDH1A1 (0.52) ALDH1A1MAPTHPGDHSD17B10KDM4E
SCHEMBL2181401 0.71 ALDH1A1 (0.67) ALDH1A1MAPTHPGDHSD17B10KDM4E
SCHEMBL7881545 0.71 TAAR1 (0.54) ALDH1A1MAPTHPGDHSD17B10KDM4E
SCHEMBL12085224 0.71 ALDH1A1 (0.52) ALDH1A1MAPTHPGDHSD17B10KDM4E
SCHEMBL3916264 0.70 MAPT (0.53) ALDH1A1MAPTHPGDHSD17B10KDM4E
SCHEMBL7420557 0.70 ALDH1A1 (0.47) ALDH1A1MAPTHPGDHSD17B10KDM4E
SCHEMBL12085233 0.70 ALDH1A1 (0.51) ALDH1A1MAPTHPGDHSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1036078-B1 THIENOPYRIMIDINES MERCK PATENT GMBH (DE) 2007-05-09 — — EP disclosed
EP-1351962-B1 THIENOPYRIMIDINE MERCK PATENT GMBH (DE) 2005-03-16 — — EP disclosed
EP-1355649-A2 PHARMACEUTICAL FORMULATION CONTAINING PYRAZOLO 4,3-D]PYRIMIDINE AND NITRATES OR THIENOPYRIMIDINES AND NITRATES MERCK PATENT GmbH (DE) 2003-10-29 — — EP disclosed
EP-1347761-A2 PHARMACEUTICAL FORMULATION CONTAINING THIENOPYRIMIDINES AND ANTITHROMBOTICS, CALCIUM ANTAGONISTS, PROSTAGLANDINS OR PROSTAGLANDIN DERIVATIVES MERCK PATENT GmbH (DE) 2003-10-01 — — EP disclosed
EP-1337256-A2 USE OF THIENOPYRIMIDINES MERCK PATENT GmbH (DE) 2003-08-27 — — EP disclosed
WO-2002060449-A2 PHARMACEUTICAL FORMULATION CONTAINING PYRAZOLO[4,3-D]PYRIMIDINE AND NITRATES OR THIENOPYRIMIDINES AND NITRATES MERCK PATENT GMBH (DE) 2002-08-08 — — WO disclosed
WO-2002049650-A2 PHARMACEUTICAL FORMULATION CONTAINING THIENOPYRIMIDINES AND ANTITHROMBOTICS, CALCIUM ANTAGONISTS, PROSTAGLANDINS OR PROSTAGLANDIN DERIVATIVES MERCK PATENT GMBH (DE) 2002-06-27 — — WO disclosed
WO-2002041896-A2 USE OF THIENOPYRIMIDINES MERCK PATENT GMBH (DE) 2002-05-30 — — WO disclosed
EP-1036078-A1 THIENOPYRIMIDINES MERCK PATENT GmbH (DE) 2000-09-20 — — EP disclosed
WO-1999028325-A1 THIENOPYRIMIDINES MERCK PATENT GMBH (DE) 1999-06-10 — — WO disclosed
Send feedback